Biomotion Sciences Ordinary Shares
Price & Volume
Stats
See more52W Range | $3.10-$63.45 |
Market Cap | $12M |
Shares Short | 113,258 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$30.78 |
News
See moreYahoo Finance • 10 days ago
Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer
Yahoo Finance • 15 days ago
Silexion Therapeutics Regains Compliance with Nasdaq Listing Requirements
Yahoo Finance • 28 days ago
Which stocks are gapping on Friday?
Yahoo Finance • 29 days ago
Silexion Therapeutics announces pricing of $6M public offering
About
CEO | Mr. Ilan Hadar M.B.A. |
CFO | Ms. Mirit Horenshtein Hadar |
Address | The Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11 |
